Calcified Tissue International

, Volume 80, Issue 6, pp 353–358 | Cite as

Bone Mineral Density Is not Sensitive Enough to Assess the Risk of Vertebral Fractures in Type 2 Diabetic Women

  • M. Yamamoto
  • T. Yamaguchi
  • M. Yamauchi
  • H. Kaji
  • T. Sugimoto


Although the association between diabetes and osteoporosis has been studied, it remains unclear if the pathogenesis of vertebral fractures in patients with type 2 diabetes would be similar to those without diabetes. One hundred and fifty female diabetic patients without apparent proteinuria as well as 716 women without diabetes (control group) were examined by lateral thoracic and lumbar spine radiographs as well as dual-energy X-ray absorptiometry. Vertebral fractures were found in 26 (17.3%) and 158 (22.1%) subjects in the diabetic and control groups, respectively. Diabetic patients had higher absolute and age-matched (Z score) values of lumbar bone mineral density (L-BMD) than controls despite their significantly higher mean age. By receiver operating characteristic (ROC) analysis, the absolute L-BMD values for detecting vertebral fractures were higher and sensitivity and specificity were lower in diabetic patients than controls (0.816 g/cm2 vs. 0.716 g/cm2 and 66.0% vs. 74.8%, respectively). Logistic regression analysis adjusted for age, body weight, and height also showed that L-BMD was not significantly associated with the presence of vertebral fractures in diabetic patients (odds ratio [OR] = 0.61, 95% confidence interval [CI] 0.34–1.09 per standard deviation increase, P = 0.0954), in contrast to the significant association in controls (OR = 0.23, 95% CI 0.16–0.33, P < 0.0001). These results show that L-BMD is not sensitive enough to assess the risk of vertebral fractures in female diabetic patients and suggest that bone fragility not defined by BMD might be related to the risk of vertebral fractures in them.


Bone fragility Bone mineral density Type 2 diabetes mellitus Vertebral fracture Receiver operating characteristic analysis 


  1. 1.
    Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM (1995) Bone loss and bone turnover in diabetes. Diabetes 44:775–782PubMedCrossRefGoogle Scholar
  2. 2.
    Lopez-Ibarra PJ, Pastor MM, Escobar-Jimenez F, Pardo MD, Gonzalez AG, Luna JD, Requena ME, Diosdado MA (2001) Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus. Endocr Pract 7:346–351PubMedGoogle Scholar
  3. 3.
    McNair P, Christiansen C, Christensen MS, Madsbad S, Faber OK, Binder C, Transbol I (1981) Development of bone mineral loss in insulin-treated diabetes: a 1½ years follow-up study in sixty patients. Eur J Clin Invest 11:55–59PubMedCrossRefGoogle Scholar
  4. 4.
    Tuominen JT, Impivaara O, Puukka P, Ronnemaa T (1999) Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22:1196–1200PubMedCrossRefGoogle Scholar
  5. 5.
    Forsen L, Meyer HE, Midthjell K, Edna TH (1999) Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia 42:920–925PubMedCrossRefGoogle Scholar
  6. 6.
    Nicodemus KK, Folsom AR Iowa Women’s Health Study (2001) Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 24:1192–1197PubMedCrossRefGoogle Scholar
  7. 7.
    Vestergaard P, Rejnmark L, Mosekilde L (2005) Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 48:1292–1299PubMedCrossRefGoogle Scholar
  8. 8.
    Isaia G, Bodrato L, Carlevatto V, Mussetta M, Salamano G, Molinatti GM (1987) Osteoporosis in type II diabetes. Acta Diabetol Lat 24:305–310PubMedGoogle Scholar
  9. 9.
    Wakasugi M, Wakao R, Tawata M, Gan N, Koizumi K, Onaya T (1993) Bone mineral density measured by dual energy X-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus. Bone 14:29–33PubMedCrossRefGoogle Scholar
  10. 10.
    Barrett-Connor E, Holbrook TL (1992) Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. JAMA 268:3333–3337PubMedCrossRefGoogle Scholar
  11. 11.
    Weinstock RS, Goland RS, Shane E, Clemens TL, Lindsay R, Bilezikian JP (1989) Bone mineral density in women with type II diabetes mellitus. J Bone Miner Res 4:97–101PubMedGoogle Scholar
  12. 12.
    Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, Jamal SA, Black DM, Cummings SR; Study of Osteoporotic Features Research Group (2001) Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86:32–38PubMedCrossRefGoogle Scholar
  13. 13.
    Black DM, Arden NK, Palermo L, Pearson J, Cummings SR (1999) Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 14:821–828PubMedCrossRefGoogle Scholar
  14. 14.
    Ross PD, Davis JW, Epstein RS, Wasnich RD (1991) Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 114:919–923PubMedGoogle Scholar
  15. 15.
    Ross PD, Genant HK, Davis JW, Miller PD, Wasnich RD (1993) Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women. Osteoporos Int 3:120–126PubMedCrossRefGoogle Scholar
  16. 16.
    Orimo H, Sugioka Y, Fukunaga M, Mutou Y, Hotokebuchi T, Gorai I, Nakamura T, Kushida K, Tanaka H, Inokai T (1996) Diagnostic criteria for primary osteoporosis in Japan [in Japanese]. Osteoporosis Japan 4:643–653Google Scholar
  17. 17.
    Genant HK, Wu CY, van Knijk C, Nevitt M (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148PubMedCrossRefGoogle Scholar
  18. 18.
    Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36PubMedGoogle Scholar
  19. 19.
    NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, Therapy (2001) Osteoporosis prevention, diagnosis, and therapy, March 7–29, 2000: highlights of the conference. South Med J 94:569–573Google Scholar
  20. 20.
    Eastell R, Cedel SL, Wahner HW, Riggs BL, Melton LJ 3rd (1991) Classification of vertebral fractures. J Bone Miner Res 6:207–215PubMedGoogle Scholar
  21. 21.
    Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254–1259PubMedGoogle Scholar
  22. 22.
    Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, Fukunaga M, Matsumoto T, Suzuki Y, Tanaka H, Fujiwara S, Miki T, Sagawa A, Nishizawa Y, Seino Y; Subcommittee to Study Diagnostic Criteria for Glucocorticoid-Induced Osteoporosis (2005) Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research. J Bone Miner Metab 23:105–109PubMedCrossRefGoogle Scholar
  23. 23.
    Gerdhem P, Isaksson A, Akesson K, Obrant KJ (2005) Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int 16:1506–1512PubMedCrossRefGoogle Scholar
  24. 24.
    Verhaeghe J, van Herck E, Visser WJ, Suiker AM, Thomasset M, Einhorn TA, Faierman E, Bouillon R (1990) Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes 39:477–482PubMedCrossRefGoogle Scholar
  25. 25.
    Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274–282PubMedGoogle Scholar
  26. 26.
    Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ (2001) Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res 16:97–103PubMedCrossRefGoogle Scholar
  27. 27.
    Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315–1321PubMedCrossRefGoogle Scholar
  28. 28.
    Wang X, Shen X, Li X, Agrawal CM (2002) Age-related changes in the collagen network and toughness of bone. Bone 31:1–7PubMedCrossRefGoogle Scholar
  29. 29.
    Saito M, Fujii K, Marumo K (2006) Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int 79:160–168PubMedCrossRefGoogle Scholar
  30. 30.
    Schwartz AV (2003) Diabetes mellitus: does it affect bone? Calcif Tissue Int 73:515–519PubMedCrossRefGoogle Scholar
  31. 31.
    Gregg EW, Beckle G, Williams DF, Leveille SG, Langlois JA, Engelgau MM, Narayan KM (2000) Diabetes and physical disability among older U.S. adults. Diabetes Care 23:1272–1277CrossRefGoogle Scholar
  32. 32.
    Ivers RQ, Cumming RG, Mitchell P, Peduto AJ; Blue Mountains Eye Study (2001) Diabetes and risk of fracture: the Blue Mountains Eye Study. Diabetes Care 24:1198–1203PubMedCrossRefGoogle Scholar
  33. 33.
    Ahmed LA, Joakimsen RM, Berntsen GK, Fonnebo V, Schirmer H (2005) Diabetes mellitus and the risk of non-vertebral fractures: the Tromso study. Osteoporos Int 10:1–6Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • M. Yamamoto
    • 1
  • T. Yamaguchi
    • 1
  • M. Yamauchi
    • 1
  • H. Kaji
    • 2
  • T. Sugimoto
    • 1
  1. 1.Department of Internal Medicine 1Shimane University Faculty of MedicineIzumoJapan
  2. 2.Divisions of Endocrinology and Metabolism, Neurology, and Hematology and Oncology, Department of Clinical Molecular MedicineKobe University Graduate School of MedicineKobeJapan

Personalised recommendations